Ut Southwestern

Dallas, Texas 75930

27 studies enrolling now · 148 studies all time

What they study most

AL Amyloidosis, AQP4+ NMOSD, Acute Coronary Syndrome, Acute Kidney Injury, Acute Myelogenous Leukemia, Adenovirus Disease, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Ovarian Carcinoma, Advanced Solid Tumor, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Recruiting now
• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
• DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma — Recruiting now
• Digoxin Medulloblastoma Study — Recruiting now
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
• A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas — Recruiting now
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — Recruiting now
• A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). — Recruiting now
• The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study — Recruiting now
• Zenith® Fenestrated+ Clinical Study — Recruiting now
• Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy — Recruiting now
• GammaPod Registry and Quality of Life Nomogram — Recruiting now
• A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue — Recruiting now
• Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy — Recruiting now
• Risk Indicators of Sarcoidosis Evolution-Unified Protocol — Recruiting now
• Blue Light Cystoscopy With Cysview® Registry — Recruiting now
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• EGCG for Hepatocellular Carcinoma Chemoprevention — Recruiting now
• Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System — Recruiting now
• Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee — Recruiting now
• A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma — Recruiting now
• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients — Stopped early
• Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation — Completed
• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Running, not enrolling
• A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Patients — Starting soon
• Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis — Running, not enrolling
• L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients — Running, not enrolling
• The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations — Completed
• 89Zr-DFO-girentuximab Expanded Access Program (EAP) — NO_LONGER_AVAILABLE
• Assessment of Combined CCM and ICD Device in HFrEF — Running, not enrolling
• ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease — Running, not enrolling
• International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry — Running, not enrolling
• Alleviant ALLAY-HF Study — Enrolling by invitation
• Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry — Running, not enrolling
• Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 — Enrolling by invitation
• Early Weight-Bearing After the Lapiplasty Procedure — Running, not enrolling
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Running, not enrolling
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
• Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy — Stopped early
• Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer — Stopped early
• Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage — Stopped early
• A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies — Stopped early
• Automated Clinical Pathway for Inflammatory Bowel Disease Care — Enrolling by invitation
• Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients — Enrolling by invitation
• A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early